- call +1-201-465-4211
- email sales@mrinsights.biz
It is used in the treatment of cancer.
Scope of the Report:
This report focuses on the Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
GlaxoSmithKline
Novartis
Sanofi and Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Market Segment by Applications, can be divided into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
There are 15 Chapters to deeply display the global Cancer Drugs market.
Chapter 1, to describe Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Drugs, with sales, revenue, and price of Cancer Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Breast Cancer
1.2.2 Blood Cancer
1.2.3 Gastrointestinal Cancer
1.2.4 Prostate Cancer
1.2.5 Skin Cancer
1.2.6 Lung Cancer
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Immunotherapy
1.3.2 Targeted Therapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi and Pfizer
2.4.1 Business Overview
2.4.2 Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi and Pfizer Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ariad Pharmaceuticals
2.9.1 Business Overview
2.9.2 Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ariad Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Eli Lilly
2.10.1 Business Overview
2.10.2 Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eli Lilly Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hoffmann-La Roche
2.11.1 Business Overview
2.11.2 Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hoffmann-La Roche Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Boehringer Ingelheim
2.12.1 Business Overview
2.12.2 Cancer Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Boehringer Ingelheim Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Johnson and Johnson
2.13.1 Business Overview
2.13.2 Cancer Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Johnson and Johnson Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Teva Pharmaceuticals
2.14.1 Business Overview
2.14.2 Cancer Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Teva Pharmaceuticals Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Drugs Market Analysis by Regions
4.1 Global Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Drugs Sales and Growth Rate (2013-2018)
4.5 South America Cancer Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Drugs Sales and Growth Rate (2013-2018)
5 North America Cancer Drugs by Countries
5.1 North America Cancer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Drugs Sales and Growth Rate (2013-2018)
6 Europe Cancer Drugs by Countries
6.1 Europe Cancer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Drugs Sales and Growth Rate (2013-2018)
6.3 UK Cancer Drugs Sales and Growth Rate (2013-2018)
6.4 France Cancer Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Drugs by Countries
7.1 Asia-Pacific Cancer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Drugs Sales and Growth Rate (2013-2018)
7.5 India Cancer Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Drugs Sales and Growth Rate (2013-2018)
8 South America Cancer Drugs by Countries
8.1 South America Cancer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Drugs by Countries
9.1 Middle East and Africa Cancer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Drugs Sales and Growth Rate (2013-2018)
10 Global Cancer Drugs Market Segment by Type
10.1 Global Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Breast Cancer Sales Growth and Price
10.2.1 Global Breast Cancer Sales Growth (2013-2018)
10.2.2 Global Breast Cancer Price (2013-2018)
10.3 Blood Cancer Sales Growth and Price
10.3.1 Global Blood Cancer Sales Growth (2013-2018)
10.3.2 Global Blood Cancer Price (2013-2018)
10.4 Gastrointestinal Cancer Sales Growth and Price
10.4.1 Global Gastrointestinal Cancer Sales Growth (2013-2018)
10.4.2 Global Gastrointestinal Cancer Price (2013-2018)
10.5 Prostate Cancer Sales Growth and Price
10.5.1 Global Prostate Cancer Sales Growth (2013-2018)
10.5.2 Global Prostate Cancer Price (2013-2018)
10.6 Skin Cancer Sales Growth and Price
10.6.1 Global Skin Cancer Sales Growth (2013-2018)
10.6.2 Global Skin Cancer Price (2013-2018)
10.7 Lung Cancer Sales Growth and Price
10.7.1 Global Lung Cancer Sales Growth (2013-2018)
10.7.2 Global Lung Cancer Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Cancer Drugs Market Segment by Application
11.1 Global Cancer Drugs Sales Market Share by Application (2013-2018)
11.2 Immunotherapy Sales Growth (2013-2018)
11.3 Targeted Therapy Sales Growth (2013-2018)
11.4 Chemotherapy Sales Growth (2013-2018)
11.5 Hormone Therapy Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Cancer Drugs Market Forecast (2018-2023)
12.1 Global Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Drugs Market Forecast (2018-2023)
12.2.2 Europe Cancer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Drugs Market Forecast (2018-2023)
12.2.4 South America Cancer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Drugs Market Forecast (2018-2023)
12.3 Cancer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Drugs Market Share Forecast by Type (2018-2023)
12.4 Cancer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Drugs Picture
Table Product Specifications of Cancer Drugs
Figure Global Sales Market Share of Cancer Drugs by Types in 2017
Table Cancer Drugs T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
